Tissue Regenix Group PLC's (LON:TRX) Daniel Lee talks to Proactive London about his experience in the sector, his new appointment as CEO as well the firm's performance for 2020.
In a trading update for the year to December 31, Lee says the revenues for the year will be £12.8mln, in line with the prior-year figure of £13mln despite the impact of the pandemic.
The regenerative medical devices specialist has also highlighted their cash position of £9.5mln following a fundraising in June.
